These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 30419863)
1. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer. Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214 [TBL] [Abstract][Full Text] [Related]
3. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma. Fu X; Li T; Dai Y; Li J BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297 [TBL] [Abstract][Full Text] [Related]
4. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection. Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Guthrie GJ; Roxburgh CS; Farhan-Alanie OM; Horgan PG; McMillan DC Br J Cancer; 2013 Jul; 109(1):24-8. PubMed ID: 23799846 [TBL] [Abstract][Full Text] [Related]
6. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A; Eo W; Lee S World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648 [TBL] [Abstract][Full Text] [Related]
7. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934 [TBL] [Abstract][Full Text] [Related]
8. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma. Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781 [TBL] [Abstract][Full Text] [Related]
9. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101. He CB; Lin XJ PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606 [TBL] [Abstract][Full Text] [Related]
11. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932 [TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host. Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264 [TBL] [Abstract][Full Text] [Related]
13. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer. Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy. Jia W; Yuan L; Ni H; Xu B; Zhao P Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689 [TBL] [Abstract][Full Text] [Related]
15. Staging the tumor and staging the host: A two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer. Park JH; Ishizuka M; McSorley ST; Kubota K; Roxburgh CSD; Nagata H; Takagi K; Iwasaki Y; Aoki T; Horgan PG; McMillan DC Am J Surg; 2018 Sep; 216(3):458-464. PubMed ID: 28967380 [TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer. Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445 [TBL] [Abstract][Full Text] [Related]
17. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer. Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536 [TBL] [Abstract][Full Text] [Related]
18. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
19. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]